Confusion Metrics: Presenting classification results on the test set. by Muhammad Zubair (728141)

Subjects:

XAI Saliency map visualization for the proposed model. by Muhammad Zubair (728141)

Subjects:

Original 2D MRI views of the brain. by Muhammad Zubair (728141)

Subjects:

Summary of recent Alzheimer’s classification studies. by Muhammad Zubair (728141)

Subjects:

SVM Hyperparameter Tuning Results Using Grid Search. by Muhammad Zubair (728141)

Subjects:

Original dataset composition (Raw from ADNI). by Muhammad Zubair (728141)

Subjects:

Class-wise performance on the test set. by Muhammad Zubair (728141)

Subjects:

Comparison of the Classification performance of the proposed model calculated on the test set with state-of-the-art Approaches. by Muhammad Zubair (728141)

Subjects:

Details of Hyperparameters. by Muhammad Zubair (728141)

Subjects:

Comparative performance analysis of different architectures. by Muhammad Zubair (728141)

Subjects:

Proposed Alzheimer’s disease classification pipeline using Multi-Scale EfficientNet with SVM. by Muhammad Zubair (728141)

Subjects:

Ablation Study Result. by Muhammad Zubair (728141)

Subjects:

Baseline characteristics of study subjects. by Md. Akeruzzaman Shaon (21511929)

Subjects:

Presentation 1_Ceftriaxone-associated dysbiosis decreases voriconazole bioavailability by upregulating intestinal P-glycoprotein expression through activation of the Nrf2-mediated... by Xiaokang Wang (733379)

“…</p>Key findings<p>The diversity and richness of intestinal bacteria, especially the abundance of gram-negative bacteria, were significantly decreased after ceftriaxone treatment. …”

Table 1_Ceftriaxone-associated dysbiosis decreases voriconazole bioavailability by upregulating intestinal P-glycoprotein expression through activation of the Nrf2-mediated signall... by Xiaokang Wang (733379)

“…</p>Key findings<p>The diversity and richness of intestinal bacteria, especially the abundance of gram-negative bacteria, were significantly decreased after ceftriaxone treatment. …”

Additional file 9 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Additional file 8 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Supplementary Table S2 from Elevated Transglutaminase-2 in SOX10-Deficient Melanoma Promotes Tumor Onset and Decreases Intratumoral CD4⁺ T Cells by Signe Caksa (16745174)

Additional file 7 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Additional file 11 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)